Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
19. August 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9040
Articles 1 - 20 / 180793
Evaluation of the safety and efficacy of (225)Ac-PSMA-CY313 in metastatic castration-resistant prostate cancer: preliminary results.
Eur Radiol Exp
Zhang H, Shi Y, Yu Y, He Z, Luo F, Wu Y, Tang T, Ma D, Li S.
PMID: 42611148 [PubMed - indexed for MEDLINE]
Ortho-Fusion Metaboliprobe for Sensitive and Specific In Situ Detection of Metabolites in Tumor-Derived Exosomes.
Anal Chem
Tian R, Kang Q, Dai X, Ding Y, Chen A, Zhang P, Yang C.
PMID: 42610891 [PubMed - indexed for MEDLINE]
Diagnostically Calibrated AI Image Quality Framework Applied to Prostate Cancer Detection at MRI.
Radiology
Coelho TF, Bosma JS, Bozgo V, Noordman CR, Grimm R, de Rooij M, Maas MC, Huisman H.
PMID: 42610819 [PubMed - indexed for MEDLINE]
The clinical significance of exploring concurrent nephropathy in patients with primary renal malignancies.
Ann Med
Zhang Y, Xiang S, Pan C, Wang J, Wang J, Fu Y, Shu C, Peng W, Lu B, Ye T, Zheng J, Tang X.
PMID: 42610678 [PubMed - indexed for MEDLINE]
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.
Eur Heart J
Ruppert M, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Henderson A, Lay-Flurrie J, Brinker M, Hofmeister L, Anker MS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Anker SD, Filippatos G.
PMID: 42610431 [PubMed - as supplied by publisher]
Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges.
Int J Nanomedicine
Li W.
PMID: 42610073 [PubMed - indexed for MEDLINE]
Cardiovascular-kidney-metabolic health, genetic susceptibility, and incident cancer risk: a prospective UK biobank cohort and machine learning study.
Front Endocrinol (Lausanne)
He X, An J, Yan C, Zhou Y, Wu Z, Xu M, He Q.
PMID: 42609333 [PubMed - indexed for MEDLINE]
Exploring Long Noncoding RNA CASC11 as a Biomarker for Bladder Cancer Detection.
Asia Pac J Clin Oncol
Luo H, Xu C, Huang S, Wang T, Gu Y.
PMID: 42608861 [PubMed - as supplied by publisher]
Clinical and genomic characterization of brain metastasis in bladder cancer.
J Neurooncol
Manoranjan B, Zeller S, Price H, Reiner AS, Rosenberg JE, Iyer G, Moss NS.
PMID: 42608487 [PubMed - indexed for MEDLINE]
Development and Validation of A Nomogram for Prostate Cancer Diagnosis Based on Inflammatory Ratios and PSA Derived Indicators.
Arch Esp Urol
Wang Y, Chen J, Kuang J, Wang X.
PMID: 42608375 [PubMed - indexed for MEDLINE]
Clinical Outcomes of CTA-Assisted Transarterial Embolization in Emergency Patients With Urologic Tumours Complicated by Gross Haematuria: A Retrospective Cohort Study.
Arch Esp Urol
Lu Y, Gu G, Liu S, Zhou X.
PMID: 42608372 [PubMed - indexed for MEDLINE]
Comparative Analysis of Disease Burden and Risk Factor Attribution for Urological Cancers in Six High-Growth GBD Regions.
Arch Esp Urol
Liu Y, Li Y, Wu T, Hu H, Hu H.
PMID: 42608371 [PubMed - indexed for MEDLINE]
Preoperative Systemic Immune-Inflammation Index Combined With Multiphasic Enhanced CT Features for Predicting Fuhrman Grade in Clear Cell Renal Cell Carcinoma: An Internally Validated Proof-of-Concept Nomogram.
Arch Esp Urol
Zhang L, Yao Y, Ye X, Qu L, Li D.
PMID: 42608370 [PubMed - indexed for MEDLINE]
An Enhanced Nursing Programme Based on mp-MRI Assessment for Urinary Continence Recovery After Radical Prostatectomy.
Arch Esp Urol
Shi C, Ding L, Zhu H, Wang T.
PMID: 42608366 [PubMed - indexed for MEDLINE]
Development of a Nomogram Incorporating Multiparametric MRI and Clinical Indicators for Predicting Positive Surgical Margins After Radical Prostatectomy.
Arch Esp Urol
Ma J, Qiu X, Ren F, Hu Y, Cui Q, Zhou X.
PMID: 42608364 [PubMed - indexed for MEDLINE]
Oncological Outcomes of Intravesical Bacillus Calmette-Guérin Versus Early Radical Cystectomy in Very High-Risk Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort From a Latin American Referral Center.
Arch Esp Urol
Alfieri AG, Ramirez F, Favre G, Tobia Gonzalez I, Zimmermann D, Gonzalez M.
PMID: 42608361 [PubMed - indexed for MEDLINE]
Cancer-Associated Thrombosis in Genitourinary Malignancies: A Real-World Analysis From the TESEO Registry.
Arch Esp Urol
Pelegrín-Mateo FJ, Grau Mirete B, Vázquez Mazón F, Rodríguez Lescure Á, Jiménez Fonseca P, Carmona Bayonas A, Fernández Pérez I, Rubio Pérez J, Ortega Morán L, Cacho Lavin D, Martínez Del Prado P, Martínez Marín M, García de Herreros M, Carmona Campos M, Muñoz Martín A.
PMID: 42608360 [PubMed - indexed for MEDLINE]
Hypofractionated Postoperative Radiotherapy in Prostate Cancer: A Real-World Single-Center Experience.
Arch Esp Urol
Navarro-Domenech I, Ordoñez-Marmolejo R, Lazo-Prados A, Otero-Romero A, Calvo-Tudela A, Jiménez-Rodríguez H, Tarazona-Vera V, Álvarez-Pérez M, Correa-Generoso R.
PMID: 42608359 [PubMed - indexed for MEDLINE]
Bone Health in Patients With Prostate Cancer Treated With Androgen Deprivation Therapy: Risk Assessment and Practical Recommendations.
Arch Esp Urol
Guardado González S, López-Campos F, Gaztañaga Boronat M, Fernández Alonso S, Zaragoza Cocero L, Glaría Enríquez LA, Gómez-Aparicio MA, Rodríguez-Izquierdo Jiménez M, García Tello A, Le Guévelou J, Couñago F.
PMID: 42608357 [PubMed - indexed for MEDLINE]
Reply to Pietro scilipoti, Giuseppe Rosiello, Andrea Salonia, Alberto Briganti, Marco Moschini, Francesco Montorsi Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.
Eur Urol Oncol
Contieri R, Hurle R.
PMID: 42608213 [PubMed - as supplied by publisher]
Articles 1 - 20 / 180793
Page 1 of 9040
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy